H.R.623 - Gabriella Miller Kids First Research Act 2.0117th Congress (2021-2022) |
|Sponsor:||Rep. Wexton, Jennifer [D-VA-10] (Introduced 01/28/2021)|
|Committees:||House - Energy and Commerce; Financial Services|
|Latest Action:||House - 02/02/2021 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.623 — 117th Congress (2021-2022)All Information (Except Text)
Introduced in House (01/28/2021)
Gabriella Miller Kids First Research Act 2.0
This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH).
Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund.
This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.